@article {1635626,
	title = {Orbital Inflammation Following COVID-19 Vaccination},
	journal = {Ophthalmic Plast Reconstr Surg},
	volume = {38},
	number = {3},
	year = {2022},
	month = {2022 May-Jun 01},
	pages = {e67-e70},
	abstract = {Three patients presented with periorbital swelling, pain with extraocular movements, and binocular diplopia 1-4 days after receiving an mRNA Coronavirus Infectious Disease-19 (COVID-19) vaccine (BNT162b2, Pfizer/BioNTech; mRNA-1273, Moderna). All patients had a normal afferent function, unilateral limitation of extraocular motility, proptosis, and periorbital inflammation. Neuroimaging of the orbits with contrast revealed inflammation and enlargement of extraocular muscles in 2 cases and the lacrimal gland in 1 case. In all 3 cases, an extensive infectious and inflammatory laboratory work-up was unremarkable and signs and symptoms of orbital inflammation rapidly improved to complete resolution after treatment with high-dose oral prednisone. This is the first reported series of orbital inflammation occurring shortly after administration of the COVID-19 vaccine. Clinicians may consider an inflammatory postvaccine etiology as an alternative to presumed idiopathic diagnosis in such cases.},
	keywords = {BNT162 Vaccine, Communicable Diseases, COVID-19, COVID-19 Vaccines, Humans, Inflammation, Vaccination},
	issn = {1537-2677},
	doi = {10.1097/IOP.0000000000002161},
	author = {Reshef, Edith R and Freitag, Suzanne K and Lee, Nahyoung Grace}
}
